Business Description
Baotou Dongbao Bio-Tech Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001583
Compare
Compare
Traded in other countries / regions
300239.China IPO Date
2011-07-06Description
Baotou Dongbao Bio-Tech Co Ltd operates in pharmaceutical manufacturing industry. The products of the company include collage, photosensitive gelatin, medicinal gelatin, edible gelatin, and calcium hydrogen phosphate.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.6 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 3.38 | |||||
Interest Coverage | 33.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.2 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.8 | |||||
3-Year EBITDA Growth Rate | 38.6 | |||||
3-Year EPS without NRI Growth Rate | 98.5 | |||||
3-Year Book Growth Rate | 13.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.52 | |||||
9-Day RSI | 44.35 | |||||
14-Day RSI | 44.22 | |||||
6-1 Month Momentum % | -21.81 | |||||
12-1 Month Momentum % | -22.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.82 | |||||
Quick Ratio | 3.78 | |||||
Cash Ratio | 2.68 | |||||
Days Inventory | 147.91 | |||||
Days Sales Outstanding | 64 | |||||
Days Payable | 75.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.47 | |||||
Dividend Payout Ratio | 0.14 | |||||
3-Year Dividend Growth Rate | -4.7 | |||||
Forward Dividend Yield % | 0.47 | |||||
5-Year Yield-on-Cost % | 0.48 | |||||
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -8.04 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.32 | |||||
Operating Margin % | 14.78 | |||||
Net Margin % | 12.01 | |||||
FCF Margin % | 6.95 | |||||
ROE % | 7.06 | |||||
ROA % | 4.5 | |||||
ROIC % | 6.93 | |||||
ROC (Joel Greenblatt) % | 10.56 | |||||
ROCE % | 6.2 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.85 | |||||
PE Ratio without NRI | 25.16 | |||||
Shiller PE Ratio | 58.97 | |||||
Price-to-Owner-Earnings | 157.67 | |||||
PEG Ratio | 1.11 | |||||
PS Ratio | 3.09 | |||||
PB Ratio | 1.67 | |||||
Price-to-Tangible-Book | 1.83 | |||||
Price-to-Free-Cash-Flow | 41.49 | |||||
Price-to-Operating-Cash-Flow | 13.67 | |||||
EV-to-EBIT | 17.98 | |||||
EV-to-EBITDA | 17.98 | |||||
EV-to-Revenue | 2.64 | |||||
EV-to-FCF | 37.98 | |||||
Price-to-Projected-FCF | 2.99 | |||||
Price-to-Median-PS-Value | 0.5 | |||||
Price-to-Peter-Lynch-Fair-Value | 1 | |||||
Price-to-Graham-Number | 1.43 | |||||
Price-to-Net-Current-Asset-Value | 9.46 | |||||
Earnings Yield (Greenblatt) % | 5.56 | |||||
FCF Yield % | 2.36 | |||||
Forward Rate of Return (Yacktman) % | 18.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baotou Dongbao Bio-Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 954.971 | ||
EPS (TTM) (Â¥) | 0.183 | ||
Beta | 0.75 | ||
Volatility % | 36.29 | ||
14-Day RSI | 44.22 | ||
14-Day ATR (Â¥) | 0.162724 | ||
20-Day SMA (Â¥) | 4.8465 | ||
12-1 Month Momentum % | -22.31 | ||
52-Week Range (Â¥) | 3.63 - 6.8 | ||
Shares Outstanding (Mil) | 593.6 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Baotou Dongbao Bio-Tech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Baotou Dongbao Bio-Tech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Baotou Dongbao Bio-Tech Co Ltd Frequently Asked Questions
What is Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239)'s stock price today?
The current price of SZSE:300239 is ¥4.73. The 52 week high of SZSE:300239 is ¥6.80 and 52 week low is ¥3.63.
When is next earnings date of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239)?
The next earnings date of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is .
Does Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) pay dividends? If so, how much?
The Dividend Yield %  of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is 0.47% (As of Today), Highest Dividend Payout Ratio of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) was 6.67. The lowest was 0.04. And the median was 0.59. The  Forward Dividend Yield % of Baotou Dongbao Bio-Tech Co Ltd(SZSE:300239) is 0.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |